Leanabl Logo

Regulatory Pathway Strategy

Define the right regulatory route before execution.

A weak pathway decision turns strategy into rework.

Route Definition

Route Definition

We define the target pathway, classification logic, review route, and decision points before your team commits to documentation or testing.

Evidence Logic

Evidence Logic

We identify the comparison strategy, clinical or performance evidence needs, and claims that can realistically be supported.

Scope Control

Scope Control

The output makes inclusions, exclusions, client inputs, assumptions, and next-phase costs visible before scope expands.

Service specification

A productized service spec, not an open-ended advisory call.

Korea Regulatory Pathway Strategy

You know what you are buying before kickoff. We define the work, boundaries, deliverables, timeline, client inputs, communication rules, and pricing terms upfront.

Request assessment

For Korea, the assessment maps MFDS or NIDS registration routes, designated technical-document review, KGMP submission file needs, importer/KLH roles, and NECA/HIRA sequencing where relevant.

Classification logic, pathway options, evidence needs, sequencing; Full submission drafting, testing execution, authority filing

Pathway memo with route, assumptions, risks, and next steps; Decision meeting for leadership and project owners

Typically 2–4 weeks after required inputs; Kickoff, document review, pathway mapping, report review

Product description, IFU, claims, current approvals, key reports; Focused SME access for clarification and review

Fixed-fee when product scope is clear; Registration delivery scoped separately after the assessment

Frequently Asked Questions

Answers to common questions about the pathway strategy service.